Breast Cancer Coverage from Every Angle

Ongoing CE Activities

14th Annual School of Breast Oncology® Online
2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Breast Cancer
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™
Adding Evidence to Front-Line Therapy of Hormone Receptor–Positive Breast Cancer (login required)
Adipose Fat Distribution a CVD Risk After Breast Cancer
Assisting Community-Based Oncologists and Surgeons in Making Treatment Decisions for Patients with ER-Positive, HER2-Negative Early Breast Cancer
NCCN 2018 Congress Webinar Series: Breast Cancer – Barriers to the Coordination of Cancer Care
NCCN 2018 Congress Webinar Series: Breast Cancer – Surveillance of Patients With Early Stage and Advanced Disease
Breast Cancer Update, Issue 3, 2019: ER-Positive Edition
Breast Cancer Update: Triple-Negative Edition
Conversations with Oncology Investigators: Bridging the Gap between Research and Patient Care
CDK 4/6 Inhibition in Breast Cancer: Self-Study Module II
CDK 4/6 Inhibition in Breast Cancer: Self-Study Module I
CDK4/6 Inhibitors: Moving Beyond the Breast Cancer Setting
Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer
Cases from the Community: Clinical Investigators Provide Their Perspectives on Actual Breast Cancer Cases and the Implications of Emerging Research
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast Cancer
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer (login required)
Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer
Elevated Breast Cancer Risk With HRT Persists
Evolving Standards in HER2-Targeted Adjuvant Therapy (login required)
Genetic/Familial High-Risk Evaluation in Patients with Breast Cancer
Herceptin: 6 or 12 Months?
Hormone Receptor-Positive Advanced Breast Cancer: Challenges and New Treatment Options
Hormone Receptor-Positive Advanced Breast Cancer: Will ESR1 Have a Role? (login required)
Implementation and Implications of AJCC Cancer Staging Manual, 8th Edition for Breast Cancer Staging
Empowering Oncology Teams to Improve Care Quality for Women with Advanced or Metastatic HR+/HER2- Breast Cancer
Clinical Strategies for Incorporating Immunotherapy in Advanced Breast Cancer: Insights for Surgeons and Oncologists
Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma
Management of HR-Positive Advanced Breast Cancer: Is There a Best Sequence? (login required)
Management of Lymphedema after Breast Cancer Treatment
Medical Crossfire®: Establishing the Role of Predictive Biomarkers and Testing Strategies for Breast Cancer Management
Medical Crossfire®: Expert Perspectives on the Emerging Role of CDK4/6 Inhibitors for the Management of Metastatic Breast Cancer
NCCN Congress Series: Breast Cancer with Updates from the 2019 San Antonio Breast Cancer Symposium
NCCN Continuing Education in Breast Cancer
NCCN Guidelines Insights: Breast Cancer, Version 3.2018
Oncology Grand Rounds Series: Part 3 — Breast Cancer: A satellite symposium held at the 2017 ONS Annual Congress
Oncology Grand Rounds: Breast Cancer
Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Management of Early and Advanced Breast Cancer
Consensus or Controversy? Clinical Investigators Provide Perspectives on Practical Issues and Ongoing Research Related to the Management of Breast Cancer
Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia
Prioritizing Women With Dense Breasts for Supplemental Imaging
Proton-Beam RT Proves Safe, Effective in Breast Cancer
Significance and Relevance of Recent Data Sets and Publications in the Management of Breast Cancer
Recorded Presentations From the NCCN 2017 Congress Webinar Series: Breast Cancer
Response to PD-L1 Drug Boosts Survival in TNBC
Real-World Strategies to Transform a Triple-Negative Breast Cancer Diagnosis Into Positive Patient Outcomes
Taxane-Based Tx May Put Breast Ca Patients Off Balance
TNBC: Improvements Gained With PD-1/L1 Inhibitors
Use of Genomic Classifiers to Inform Clinical Decision-Making for Patients with Early Breast Cancer
Data + Perspectives: Biologic Basis and Available Clinical Research Underlying the Protocol and Nonresearch Use of PARP Inhibition in Patients with Ovarian and Breast Cancer
Virtual Molecular Tumor Board - A Webcast Series Exploring the Role of Molecular Profiling in Metastatic Breast Cancer (login required)
Virtual Patient Simulation: Case Studies in Early Stage HER2+ Breast Cancer (login required)
What Would You Do? Managing HR-Positive Advanced Breast Cancer
Year in Review: Proceedings from the Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.